Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT

Bone Marrow Transplantation

Volumn 50, Issue 7, 2015, Pages 999-1000

  O'Neill, A ^a   Mikesch, K ^b   Fritsch, K ^c   Kasenda, B ^b   Banerjee, L ^a   Burns, F ^a,d   Zakout, G ^a   Johnston, R ^e   Illerhaus, G ^b   Cwynarski, K ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b KLINIKUM STUTTGART   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CARMUSTINE; COTRIMOXAZOLE; CYTARABINE; METHOTREXATE; RITUXIMAB; TENOFOVIR; THIOTEPA;

ADULT; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CANCER STAGING; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFUSION; CYTOMEGALOVIRUS; CYTOPENIA; DIPLOPIA; DISEASE ASSOCIATION; DROWSINESS; DRUG MEGADOSE; DRUG TOLERANCE; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; FEVER; HEADACHE; HEPATITIS C VIRUS SUBTYPE 1A; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ABUSE; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; LIVER CIRRHOSIS; LUNG LAVAGE; MACULOPAPULAR RASH; MALE; MEDICAL HISTORY; MEMORY DISORDER; MIDDLE AGED; MONOTHERAPY; MORTALITY; MULTIPLE CYCLE TREATMENT; MULTIPLE ORGAN FAILURE; NEUROIMAGING; NEUTROPENIC SEPSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; POLYMERASE CHAIN REACTION; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; SEPSIS; SEROLOGY; TOXOPLASMA GONDII; TREATMENT REFUSAL; TREATMENT RESPONSE; VIRUS LOAD; VIRUS REACTIVATION; WHOLE BODY RADIATION; CASE REPORT; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMPLICATION; IMMUNOLOGY; LYMPHOMA, NON-HODGKIN; PATHOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84934862537     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.18     Document Type: Letter

References (14)

1. Dolecek T, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 2012; 14: v1-v49.
2. Coté TR, Manns A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst. 1996; 88: 675-679.
3. Zhang Y, Peng J, Tang Y, He J, Peng J, Zhao Q et al. The prevalence of Epstein-Barr virus infection in different types and sites of lymphomas. Jpn J Infect Dis 2010; 63: 132-135.
4. Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 2009; 374: 1512-1520.
5. Schorb E, Kasenda B, Atta J, Kaun S, Morgner A, Hess G et al. Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation. Haematologica 2013; 98: 765-770.
6. Bower M, Fife K, Sullivan A, Kirk S, Phillips RH, Nelson M et al. Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma. Eur J Cancer 1999; 35: 601-604.
7. Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS 2014; 28: 453-465.
8. Bayraktar S, Bayraktar UD, Ramos JC, Stefanovic A, Lossos IS. Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors. J Neurooncol 2011; 101: 257-265.
9. Gopal S, Martin KE, Richards KL, Eron JJ. Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010. AIDS Res Hum Retroviruses 2012; 28: 798-805.
10. González-Aguilar A, Soto-Hernández JL. The management of primary central nervous system lymphoma related to AIDS in the HAART era. Curr Opin Oncol 2011; 23: 648-653.
11. Bower M, Palfreeman A, Alfa-Wali M, Bunker C, Burns F, Churchill D et al. British HIV Association guidelines for HIV-associated malignancies 2014. British HIV Association. HIV Med 2014; 15: 1-92.
12. Diez-Martin JL, Balsalobre P, Re A, Michieli M, Ribera JM, Canals C et al. Comparable survival between HIV+ and HIV-non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 2009; 113: 6011-6014.
13. Balsalobre P, Diez-Martin JL, Re A, Michieli M, Ribera JM, Canals C et al. Autologous stem-cell transplantation in patients with HIV-related lymphoma. J Clin Oncol 2009; 27: 2192-2198.
14. Wolf T, Kiderlen T, Atta J, Stephan C, Kann G, Brodt HR et al. Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab-and methotrexatebased chemotherapy and autologous stem cell transplant. Infection 2014; 42: 445-447.